When will COVID-19 vaccines be available for children under 12 years of age?

When will COVID-19 vaccines be available for children under 12 years of age?

Although the corona vaccine is available in the market, it is only approved for use by those 18 years of age and older. However, only one of these vaccines is available for children ages 12 years and up. The rest of the vaccines are in various stages of clinical trials in young children. If the results are promising, the vaccination of young children may begin in the next few months.

  1. Pfizer vaccine: The Pfizer vaccine is currently only approved for people ages 12 years and older. The vaccine is now under clinical trial for children aged between 6 months and 11 years. The manufacturer is hopeful that they are expected to apply for the authorization for children ages 2 to 11 years by coming September if all goes well. In that case, its implementation will start within a few weeks of getting the approval.

  2. Moderna Vaccines: Moderna vaccines are currently approved for 18 years of age and older. However, in May this year, the company announced the results of preliminary trials on the 12 to 18 years. The promising data show that the vaccine is very safe and effective in preventing coronavirus in this age group. Last June, Modern said to apply for authorization to use for 12 to 18-year-olds in a few weeks. Simultaneously, they are also testing their vaccine in children aged between 6 months and 11 years. With expected positive outcomes, the company is optimistic that the vaccine may be introduced in children under the age of 12 by November-December this year or by early 2022.

  3. Johnson & Johnson Vaccine: Johnson & Johnson has already planned to test their corona vaccine in young children and adolescents this fall. It is the only single-dose vaccine currently being used for people 18 years of age or older. A total of four stages of vaccine testing for children are being planned so far. The first trial will be conducted on 12 to 18-year-olds and the next stages will include children 11 years and younger. The company already plans to enroll about 4,500 participants between the ages of 12 and 17.

  4. Oxford-AstraZeneca Vaccine: A vaccine developed jointly by Oxford University and AstraZeneca is approved for 18 years of age or older. The AstraZeneca vaccine is commonly known as Covishield in India. In mid-February, the company began clinical trials for this vaccine on 6 to 18-year-olds. About 200 participants were enrolled in the study. But the trial had to be put on hold due to the rare side effects of blood clotting in adults. The vaccine is temporarily discontinued in the USA and most of the European countries and is waiting for further studies.

  5. Covaxin: India-made Covaxin has already been used for adults. Recently the company has received a green signal to test their vaccine on people ages between 2 and 16 years. The trials will be conducted in about 525 centers across the country. The results are expected in the next few months.

  6. Sputnik V vaccine: After a long wait, the use of the Sputnik V vaccine has started in India. This is a Russia-made vaccine. The manufacturer recently announced that they will soon begin testing the Sputnik V vaccine in children's with a study design based on age and weight.

So, if everything goes well, COVID-19 vaccines are expected to be introduced in young children in the next few weeks or months. Until then, maintaining proper hygiene and following corona restrictions are the best possible ways to prevent coronavirus spread.